id stringlengths 14 15 | text stringlengths 51 2.13k | source stringlengths 44 128 |
|---|---|---|
f1aa3844ae43-2 | You should not consider the information in this site to be specific, professional medical advice for your personal health or for your family’s personal health. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult a healthcare professional.
A B C D E F... | mvec.mcri.edu.au/references/pots-postural-tachycardia-syndrome-and-immunisation/index.html |
70b843f0638a-0 | Background
The spleen plays an important role in preventing infection by removing bacteria (particularly encapsulated bacteria) from the blood stream. Individuals with anatomical asplenia (absent spleen) or functional asplenia/hyposplenia (no function or decreased function) are therefore at an increased risk of infecti... | mvec.mcri.edu.au/references/hyposplenia/index.html |
70b843f0638a-1 | Additional vaccine recommendations for children (< 18 years)
Pneumococcal
Vaccine brand Prevenar 13® (pneumococcal conjugate vaccine 13vPCV) Pneumovax 23® (pneumococcal polysaccharide vaccine 23vPPV) Age at diagnosis ≥ 6 weeks to ≤ 11 months 3 doses (min. 8 weeks apart) + 1 booster¥β§Single dose at ≥ 4 years^≥ 12 month... | mvec.mcri.edu.au/references/hyposplenia/index.html |
70b843f0638a-2 | N/A- not recommended.
Meningococcal
Vaccine brand Nimenrix® (meningococcal quadrivalent conjugate vaccine 4vMenCV ACWY) Bexsero® (meningococcal B recombinant multicomponent vaccine MenBV) Age at diagnosis ≥ 6 weeks to ≤ 5 months 3 doses (min. 8 weeks apart) + 1 booster^#†3 doses (minimum 8 weeks apart) + 1 booster dose... | mvec.mcri.edu.au/references/hyposplenia/index.html |
70b843f0638a-3 | ¥ administration of prophylactic paracetamol is recommended for those < 4 years of age (15mg/kg per dose) 30 minutes prior to vaccination (or as soon as possible after), as well as 2 subsequent doses (4-6 hours apart) to reduce the likelihood and severity of fever.
† Menveo® may be used interchangeably as an alternate ... | mvec.mcri.edu.au/references/hyposplenia/index.html |
70b843f0638a-4 | Additional vaccine recommendations for adults (≥ 18 years)
Pneumococcal
Vaccine brand Prevenar 13® (pneumococcal conjugate vaccine 13vPCV) Pneumovax 23® (pneumococcal polysaccharide vaccine 23vPPV) Dose Single dose at diagnosis⧥^Single dose (min. 8 weeks following completion of Prevenar 13®)⥆Additional booster dose... | mvec.mcri.edu.au/references/hyposplenia/index.html |
70b843f0638a-5 | N/A- not recommended.
Meningococcal
Vaccine brand Nimenrix® (meningococcal quadrivalent conjugate vaccine 4vMenCV ACWY) Bexsero® (meningococcal B recombinant multicomponent vaccine MenBV) Dose 2 doses (min. 8 weeks apart)߆^§2 doses (min. 8 weeks apart)ßΩAdditional booster doses Give a booster dose every 5 years follow... | mvec.mcri.edu.au/references/hyposplenia/index.html |
70b843f0638a-6 | ¥ there is no maximum number or doses in a lifetime.
Ω Trumenba® is an alternate meningococcal vaccine available as a 3 dose course for individuals asplenia/hyposplenia aged 10 years or older. Meningococcal B vaccines are not interchangeable for primary courses or booster doses.
Haemophilus influenzae type B (HIB)
Vacc... | mvec.mcri.edu.au/references/hyposplenia/index.html |
70b843f0638a-7 | Date: March 28, 2023
Materials in this section are updated as new information and vaccines become available. The Melbourne Vaccine Education Centre (MVEC) staff regularly reviews materials for accuracy.
You should not consider the information in this site to be specific, professional medical advice for your personal he... | mvec.mcri.edu.au/references/hyposplenia/index.html |
1bdd81e0d4cd-0 | Background
As a pillar of the ACT Accelerator (Access to COVID-19 Tools) partnership, COVAX is a global vaccine access initiative, co-led by Gavi (the Vaccine Alliance), the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization, alongside UNICEF. The objective of COVAX is to accelerat... | mvec.mcri.edu.au/references/covax-facility/index.html |
1bdd81e0d4cd-1 | Date: January 2022
Materials in this section are updated as new information and vaccines become available. The Melbourne Vaccine Education Centre (MVEC) staff regularly reviews materials for accuracy.
You should not consider the information in this site to be specific, professional medical advice for your personal heal... | mvec.mcri.edu.au/references/covax-facility/index.html |
89e9f4fa4850-0 | Hepatitis B is an infection caused by the hepatitis B virus resulting in jaundice, nausea, vomiting, pain and fever.
Disease is transmitted via blood and body fluids of an infected person.
Initial hepatitis B infection can often be asymptomatic, meaning a person may be unaware that they are carrying the infection.
Foll... | mvec.mcri.edu.au/references/hepatitis-b/index.html |
89e9f4fa4850-1 | Serological testing
Performing hepatitis B serology following hepatitis B vaccination is not routinely indicated.
Post vaccination screening, carried out 4-weeks after the final vaccine dose, is recommended for those at significant occupational risk (eg health care workers), those at risk of severe complications of hep... | mvec.mcri.edu.au/references/hepatitis-b/index.html |
89e9f4fa4850-2 | Age at diagnosis of disease
Anti-HBs titre
Twinrix® Adult (720/20)#
Serology
< 12 months
2 doses (separated by 6 months)
[Commence vaccine course at ≥ 12-months of age]
At diagnosis
1 month post 2nd dose of Twinrix® Adult (month 7)
Every 12 months thereafter
≥ 12 months
If baseline titre at diagnosis is ≥ 10m IU/mL:
2 ... | mvec.mcri.edu.au/references/hepatitis-b/index.html |
89e9f4fa4850-3 | Persistant non-responders should be informed of their immune status and advised to minimise exposures.
Hepatitis B immunoglobulin may be given to non-immune persons within 72 hours of exposure to prevent infection.
Reference
Tung J, Carlisle E, Smieja M, Kim PT, Lee CH. A Randomized Clinical Trial of Immunization With ... | mvec.mcri.edu.au/references/hepatitis-b/index.html |
89e9f4fa4850-4 | You should not consider the information in this site to be specific, professional medical advice for your personal health or for your family’s personal health. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult a healthcare professional.
A B C D E F... | mvec.mcri.edu.au/references/hepatitis-b/index.html |
6d98d34477bf-0 | Background
The spleen plays an important role in preventing infection by removing bacteria (particularly encapsulated bacteria) from the blood stream. Individuals with anatomical asplenia (absent spleen) or functional asplenia/hyposplenia (no function or decreased function) are therefore at an increased risk of infecti... | mvec.mcri.edu.au/references/asplenia/index.html |
6d98d34477bf-1 | Additional vaccine recommendations for children (< 18 years)
Pneumococcal
Vaccine brand Prevenar 13® (pneumococcal conjugate vaccine 13vPCV) Pneumovax 23® (pneumococcal polysaccharide vaccine 23vPPV) Age at diagnosis ≥ 6 weeks to ≤ 11 months 3 doses (min. 8 weeks apart) + 1 booster¥β§Single dose at ≥ 4 years^≥ 12 month... | mvec.mcri.edu.au/references/asplenia/index.html |
6d98d34477bf-2 | N/A- not recommended.
Meningococcal
Vaccine brand Nimenrix® (meningococcal quadrivalent conjugate vaccine 4vMenCV ACWY) Bexsero® (meningococcal B recombinant multicomponent vaccine MenBV) Age at diagnosis ≥ 6 weeks to ≤ 5 months 3 doses (min. 8 weeks apart) + 1 booster^#†3 doses (minimum 8 weeks apart) + 1 booster dose... | mvec.mcri.edu.au/references/asplenia/index.html |
6d98d34477bf-3 | ¥ administration of prophylactic paracetamol is recommended for those < 4 years of age (15mg/kg per dose) 30 minutes prior to vaccination (or as soon as possible after), as well as 2 subsequent doses (4-6 hours apart) to reduce the likelihood and severity of fever.
† Menveo® may be used interchangeably as an alternate ... | mvec.mcri.edu.au/references/asplenia/index.html |
6d98d34477bf-4 | Additional vaccine recommendations for adults (≥ 18 years)
Pneumococcal
Vaccine brand Prevenar 13® (pneumococcal conjugate vaccine 13vPCV) Pneumovax 23® (pneumococcal polysaccharide vaccine 23vPPV) Dose Single dose at diagnosis⧥^Single dose (min. 8 weeks following completion of Prevenar 13®)⥆Additional booster dose... | mvec.mcri.edu.au/references/asplenia/index.html |
6d98d34477bf-5 | N/A- not recommended.
Meningococcal
Vaccine brand Nimenrix® (meningococcal quadrivalent conjugate vaccine 4vMenCV ACWY) Bexsero® (meningococcal B recombinant multicomponent vaccine MenBV) Dose 2 doses (min. 8 weeks apart)߆^§2 doses (min. 8 weeks apart)ßΩAdditional booster doses Give a booster dose every 5 years follow... | mvec.mcri.edu.au/references/asplenia/index.html |
6d98d34477bf-6 | ¥ there is no maximum number or doses in a lifetime.
Ω Trumenba® is an alternate meningococcal vaccine available as a 3 dose course for individuals asplenia/hyposplenia aged 10 years or older. Meningococcal B vaccines are not interchangeable for primary courses or booster doses.
Haemophilus influenzae type B (HIB)
Vacc... | mvec.mcri.edu.au/references/asplenia/index.html |
6d98d34477bf-7 | Date: March 28, 2023
Materials in this section are updated as new information and vaccines become available. The Melbourne Vaccine Education Centre (MVEC) staff regularly reviews materials for accuracy.
You should not consider the information in this site to be specific, professional medical advice for your personal he... | mvec.mcri.edu.au/references/asplenia/index.html |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.